483 Watson Pharmaceuticals Sep 2011

483 Watson Pharmaceuticals Sep 2011

John Gonzalez FDA$119.00 - Available Now

FDA investigators audited the Watson Pharmaceuticals - Corona, CA, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2011
  • Location: Corona, United States
  • FEI: 3003944123
Add To Cart